Dr. Judy Boughey | San Antonio Breast Cancer Symposium 2022 | General Session

Dr. Judy Boughey | San Antonio Breast Cancer Symposium 2022 | General Session

San Antonio Breast Cancer Symposium

Judy Boughey, SABCS 2022: Breast conservation therapy in multiple ipsilateral breast cancer

Touch Medical Media

Breast-conserving therapy may be a treatment option for some patients with multiple breast lesions

Dr. Judy Boughey on Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

Dr. Adentunji Toriola | San Antonio Breast Cancer Symposium 2022

San Antonio Breast Cancer Symposium

Dr. Jan Liefers Gerrit | San Antonio Breast Cancer Symposium 2022 | General Session

San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium 2022 highlights

Dr. Jennifer Pietenpol | San Antonio Breast Cancer Symposium 2022

San Antonio Breast Cancer Symposium

De-escalating surgery for patients with early-stage breast cancer

Breast Cancer Genome Guided Therapy (BEAUTY) Study - Matthew Goetz, M.D., & Judy Boughey, M.D.

Dr. Li Ping Ge | San Antonio Breast Cancer Symposium 2022 | General Session

San Antonio Breast Cancer Symposium

Dr. Claudine Isaacs | San Antonio Breast Cancer Symposium 2022 (1) | General Session

San Antonio Breast Cancer Symposium

Dr. Polly Niravath | San Antonio Breast Cancer Symposium 2022 | General Session

San Antonio Breast Cancer Symposium

Dr. Boughey Discusses the Z11 Trial in Breast Cancer

Targeted Oncology

Raising the Bar in HR+/HER2- Early Breast Cancer: CDK4 and 6 Inhibitors

PeerView Oncology

The San Antonio Breast Cancer Symposium (SABCS) 2022

Dr. Peter A. Fasching | San Antonio Breast Cancer Symposium 2022 | General Session

San Antonio Breast Cancer Symposium

Dr. Boughey on Locoregional Trials for Breast Cancer

Dr. Boughey Discusses the Z11 Trial in Breast Cancer

Alliance ACOSOG Z11102: impact of breast conservation therapy on local recurrence in pts with MIBC